$KZIA

$8.70▲ +2.4% YTD

14 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

KZIA ▲ +2.4% - Kazia Therapeutics Limited

CP $8.70▲ +2.4%Nov 2, 2026 · ThinkSabio Blog

$KZIA KZIA - Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026…

News

KZIA ▲ +8.1% - Kazia Therapeutics Limited

CP $8.99▲ +8.1%Oct 29, 2026 · ThinkSabio Blog

$KZIA KZIA - Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference…

SEC 13D/G

KZIA - Kazia Therapeutics Limited - SEC Filing Update (02-OCT-2026) | ThinkSabio - Stocks Simplified

$9.20▲ 69.12%Oct 2, 2026 · ThinkSabio Blog

$KZIA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #KZIA Kazia Therapeutics Limited : $9.20 Sector: Healthcare | YT…

News

KZIA ▲ +0.6% - Kazia Therapeutics Limited

CP $10.71▲ +0.6%Sep 22, 2026 · ThinkSabio Blog

$KZIA KZIA - Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders…

News

KZIA ▲ +0.9% - Kazia Therapeutics Limited

CP $12.16▲ +0.9%Sep 9, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain…

News

KZIA ▲ +2.5% - Kazia Therapeutics Limited

CP $14.11▲ +2.5%Sep 1, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enha…

News

KZIA ▲ +4.6% - Kazia Therapeutics Limited

CP $14.40▲ +4.6%Sep 1, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clini…

News

KZIA ▲ +3.4% - Kazia Therapeutics Limited

CP $14.04▲ +3.4%Aug 31, 2026 · ThinkSabio Blog

$KZIA KZIA - Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering…

News

KZIA ▼ -12.0% - Kazia Therapeutics Limited

CP $15.00▲ -12.0%Aug 28, 2026 · ThinkSabio Blog

$KZIA $120M offering priced at $15.50/ADS…

News

KZIA ▼ -12.0% - Kazia Therapeutics Limited

CP $15.00▲ -12.0%Aug 28, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering…

News

KZIA ▼ -18.3% - Kazia Therapeutics Limited

CP $11.93▲ -18.3%Aug 27, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Limited Announces Proposed Public Offering…

News

KZIA ▲ +1.1% - Kazia Therapeutics Limited

CP $14.76▲ +1.1%Aug 27, 2026 · ThinkSabio Blog

$KZIA KZIA KZIA - Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer…

SEC 13D/G

KZIA - Kazia Therapeutics Limited - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks Simplified

$14.07▲ 158.64%Aug 19, 2026 · ThinkSabio Blog

$KZIA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #KZIA Kazia Therapeutics Limited : $14.07 Sector: Healthcare | Y…

SEC 13D/G

KZIA - Kazia Therapeutics Limited - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$13.52▲ 148.53%Aug 15, 2026 · ThinkSabio Blog

$KZIA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #KZIA Kazia Therapeutics Limited : $13.52 Sector: Healthcare | Y…